Unknown PHASE4 INTERVENTIONAL 3-arm NCT01661556

Clinical Trial of Hydroquinone Versus Miconazol in Melasma

Double Blind Randomized Study of 2% Miconazol Versus 4% Hydroquinone in the Treatment for Melasma.

Sponsor: Hospital Central Dr. Ignacio Morones Prieto

Conditions Melasma

Updated 6 times since 2017 Last updated: Dec 1, 2014 Started: Oct 31, 2011 Primary completion: Feb 28, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Melasma and is currently ongoing. Hospital Central Dr. Ignacio Morones Prieto leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Central Dr. Ignacio Morones Prieto
Universidad Autonoma de San Luis Potosí

Data source: Universidad Autonoma de San Luis Potosí

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Luis Potosí City, Mexico